Global Dialysis & Apheresis Market Anticipated to Reach US$ 34,519.3 Million by 2031

According to a recent market study published by Growth Market Reports, titled, “Global Dialysis & Apheresis Market by Type, By End-use, and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 19,079.2 Million in 2022 and is anticipated to expand at a growth rate of 7.1% by 2031.

Dialysis is a medical treatment that facilitates the removal of waste products from the blood of a person when the kidneys stop functioning properly. It often involves diverting blood to a machine to be cleaned.

Get Sample Report @ https://growthmarketreports.com/request-sample/5625

Dialysis is necessary for two different situations:

1- Acute kidney injury (AKI): It is referred to as acute renal failure (ARF), in which slow deterioration of kidney function or persistent kidney dysfunction is associated with an irreversible loss of kidney cells and nephrons, which lead to chronic kidney disease (CKD). AKI influences other organs such as the brain, heart, and lungs. Acute kidney injury mostly occurs in patients who are in hospitals, in intensive care units, and especially in older adults. AKI is usually treated in a hospital setting with intravenous fluids (given through the vein). In severe cases, dialysis is needed for a short time until the kidneys function well.

2- Kidney failure: This is also known as end-stage kidney disease (ESKD). Dialysis is a temporary solution for kidney failure; however, it is not a permanent solution or cure for kidney disease. A person diagnosed with ESKD needs dialysis for the rest of the life or until a kidney transplant takes place.

The Global Dialysis & Apheresis Market has been segmented in terms of type, end-use, and region. In terms of type, the Global Dialysis & Apheresis Market is split into Devices and Consumables. On the basis of end-use, the market is fragmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic has affected dialysis equipment production and the import & export of raw materials and finished goods in various COVID-19-affected countries. This lockdown created a shortage of equipment and supply chain disruption, which reduced consumer demand to some degree and impacted the availability of peritoneal dialysis, hemodialysis, and critical drugs, decreasing the number of dialysis procedures being conducted in dialysis centers. The COVID-19 pandemic surged the demand for in-home dialysis demand around the world. In comparison to healthy people, patients with diabetes and ESRD are more likely to develop COVID-19 complications. In the midst of the crisis, each country is taking steps to ensure patient safety. During the initial wave of the global pandemic in 2020 many healthcare systems have canceled or delayed the dialysis procedures, thereby restraining a wide range of dialysis equipment sales and decreasing their market values in 2020.

Key Takeaways from the Study:

• Players in the Global Dialysis & Apheresis Market include Asahi Kasei Medical Co., Ltd., Baxter, B. Braun Medical Inc., BD, Fresenius Medical Care AG & Co. KGaA, Haemonetics Corporation, Medtronic, Nikkiso Co., Ltd., NIPRO, TERUMO, and other prominent players.

• Emerging Markets and Home-based Dialysis are expected to create opportunities in the coming years.

• Based on type, the market is segmented into Devices and Consumables. The Devices segment is expected to hold a considerable share of the market during the forecast period, owing to the rising demand for dialysis and apheresis procedures. Risk of chronic kidney disease is prevailing in the region, due to the rising cases of diabetes. Diabetes is one of the prominent causes of chronic kidney disease (CKD). According to the National Library of Medicine, 7% of the population in the UK lived with diabetes in 2019, approximately one million people have undiagnosed type 2 diabetes, 40,000 children have diabetes, and more than 3000 children are diagnosed with diabetes every year.

• Based on the end-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare. The Hospitals segment is anticipated to expand at a significant CAGR during the forecast period. Significant rise in the number of old-aged people has been registered in the region. Old people generally require medical attention and are likely to have chronic health conditions that require hospital care. This trend has increased the demand for hospitals and specialized services to cater to the unique healthcare needs of the elderly.

• Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  Europe accounted for a significant share of the market in 2022, due to the rising healthcare expenditure in the country. For instance, total current healthcare expenditure in the UK accounted for 12.4% of gross domestic product (GDP) in 2021, slightly higher than the proportion it represented in 2020.

Report Scope:

Target Audience:

• Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.

• Regulatory Side: Concerned government authorities, and other approved regulatory bodies.